Author:
Papathanou Maria,Rose Sarah,McCreary Andrew,Jenner Peter
Reference50 articles.
1. Pergolide monotherapy in the treatment of early PD: a randomized, controlled study. Pergolide Monotherapy Study Group;Barone;Neurology,1999
2. Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson’s disease;Bezard;J. Neurosci.,2001
3. Differential effect of selective D-1 and D-2 dopamine receptor agonists on levodopa-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine- exposed monkeys;Blanchet;J. Pharmacol. Exp. Ther.,1993
4. DOPA-induced “peak dose” dyskinesia: clues implicating D2 receptor-mediated mechanisms using dopaminergic agonists in MPTP monkeys;Blanchet;J. Neural Transm. Suppl.,1995
5. Pergolide in the treatment of patients with early and advanced Parkinson’s disease;Bonuccelli;Clin. Neuropharmacol.,2002
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献